Thrivent Financial for Lutherans’s N-able NABL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$232K Sell
49,749
-1,465
-3% -$8.18K ﹤0.01% 2455
2025
Q4
$383K Sell
51,214
-2,777
-5% -$21.2K ﹤0.01% 2343
2025
Q3
$421K Buy
53,991
+1,164
+2% +$9.33K ﹤0.01% 2140
2025
Q2
$428K Buy
52,827
+979
+2% +$7.31K ﹤0.01% 2203
2025
Q1
$368K Sell
51,848
-2,712
-5% -$24.1K ﹤0.01% 2176
2024
Q4
$510K Sell
54,560
-716
-1% -$8.02K ﹤0.01% 2244
2024
Q3
$722K Sell
55,276
-3,009
-5% -$40.3K ﹤0.01% 2083
2024
Q2
$888K Sell
58,285
-2,018
-3% -$26.6K ﹤0.01% 1928
2024
Q1
$788K Sell
60,303
-1,638
-3% -$21.7K ﹤0.01% 2017
2023
Q4
$821K Sell
61,941
-1,506
-2% -$19.1K ﹤0.01% 1957
2023
Q3
$818K Sell
63,447
-985
-2% -$13.4K ﹤0.01% 1869
2023
Q2
$928K Sell
64,432
-1,821
-3% -$25.2K ﹤0.01% 1853
2023
Q1
$875K Buy
+66,253
New +$732K ﹤0.01% 1861

Other funds holding NABL

Thrivent Financial for Lutherans's NABL Position: Q1 2026 in Review

Thrivent Financial for Lutherans reduced its N-able (NABL) stake by 2.9% in Q1 2026, selling an estimated $8.18K and leaving 49,749 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #2455.

Thrivent Financial for Lutherans first reported a position in NABL in Q1 2023 and has held it in 13 quarters since. The position peaked at $928K in Q2 2023. 215 funds tracked by Wall St. Rank hold NABL as of Q1 2026.

  • Thrivent Financial for Lutherans held 49,749 shares of N-able worth $232K as of Q1 2026.
  • Thrivent Financial for Lutherans sold 1,465 N-able shares in Q1 2026, an estimated $8.18K.
  • N-able made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #2455 holding.
  • Thrivent Financial for Lutherans first reported a position in N-able in Q1 2023 and has held it in 13 quarters since.
  • Thrivent Financial for Lutherans's N-able position peaked at $928K in Q2 2023.
  • 215 funds tracked by Wall St. Rank held N-able as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.